BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 205961)

  • 1. Immunity, herpes simplex virus, and cervical carcinoma.
    Mumford DM; Kaufman RH; McCormick N
    Surg Clin North Am; 1978 Feb; 58(1):39-54. PubMed ID: 205961
    [No Abstract]   [Full Text] [Related]  

  • 2. [Serological aspects of the relation between herpes virus and cervico-uterine cancer].
    Suárez M; Del Campo G; Ojeda JM
    Rev Chil Obstet Ginecol; 1983; 48(1):11-5. PubMed ID: 6099904
    [No Abstract]   [Full Text] [Related]  

  • 3. Presence of herpes simplex virus type 2 (HSV-2) antibodies and antigens in patients with cervical carcinoma in Thailand.
    Puthavathana P; Srivatanakul P; Thanapatra S; Kosiyatrakul T; Phitakpraiwan P
    J Med Assoc Thai; 1980 Oct; 63(10):560-7. PubMed ID: 6255050
    [No Abstract]   [Full Text] [Related]  

  • 4. [Relationship between Herpes simplex virus type 2 and carcinoma of the uterine cervix].
    Janda J
    Cesk Gynekol; 1973 Jul; 38(6):454-60. PubMed ID: 4354419
    [No Abstract]   [Full Text] [Related]  

  • 5. Prevalence of antibodies against herpes simplex and adenovirus in oral and cervical cancer patients--a preliminary report.
    Kumari TV; Shanmugam J; Prabha B; Vasudevan DM
    Indian J Med Res; 1982 Apr; 75():590-2. PubMed ID: 6286474
    [No Abstract]   [Full Text] [Related]  

  • 6. Genital herpes virus findings in relation to cervical neoplasia.
    Royston I; Aurelian L; Davis HJ
    J Reprod Med; 1970 Apr; 4(4):9-13. PubMed ID: 4328889
    [No Abstract]   [Full Text] [Related]  

  • 7. Application of indirect hemagglutination test to measurement of type specific antibody to herpes simplex virus in human sera.
    Ohashi M; Ozaki Y
    Microbiol Immunol; 1979; 23(8):801-4. PubMed ID: 232237
    [No Abstract]   [Full Text] [Related]  

  • 8. Letter: Herpesvirus type 2 infection and cervical carcinoma.
    Royston I
    Am J Obstet Gynecol; 1974 Apr; 118(8):1152-3. PubMed ID: 4361703
    [No Abstract]   [Full Text] [Related]  

  • 9. Estimation of specific antibody to type 2 Herpes simplex virus among patients with carcinoma of the uterine cervix.
    Kawana T; Yoshino K; Kasamatsu T
    Gan; 1974 Oct; 65(5):439-45. PubMed ID: 4373302
    [No Abstract]   [Full Text] [Related]  

  • 10. AG-4 complement-fixing antibodies in cervical cancer and herpes-infected patients using local herpes simplex virus type 2.
    Arsenakis M; Georgiou GM; Welsh JK; Cauchi MN; May JT
    Int J Cancer; 1980 Jan; 25(1):67-71. PubMed ID: 6249764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Herpes type-2 viruses and gynaecological malignancies.
    Adelusi B; Fabiyi A; Osunkoya BO
    Int J Gynaecol Obstet; 1976; 14(3):209-12. PubMed ID: 13005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of herpes virus in cancer of the cervix.
    Wilbanks GD
    Obstet Gynecol Annu; 1976; 5():315-29. PubMed ID: 185549
    [No Abstract]   [Full Text] [Related]  

  • 13. The association of Herpes simplex virus and cervical cancer: a review.
    Simon JW
    Gynecol Oncol; 1976 Mar; 4(1):108-16. PubMed ID: 186361
    [No Abstract]   [Full Text] [Related]  

  • 14. Herpesviruses and cervical cancer.
    Sever JL
    Cancer Res; 1974 May; 34(5):1090. PubMed ID: 4366983
    [No Abstract]   [Full Text] [Related]  

  • 15. Herpesvirus antibody and carcinoma in situ of the cervix.
    Catalano LW; Johnson LD
    JAMA; 1971 Jul; 217(4):447-50. PubMed ID: 4326405
    [No Abstract]   [Full Text] [Related]  

  • 16. Prevalence of antibodies to herpes simplex virus and frequency of HLA antigens in patients with preinvasive and invasive cervical cancer.
    Vass-Sørensen M; Abeler V; Berle E; Pedersen B; Davy M; Thorsby E; Norrild B
    Gynecol Oncol; 1984 Jul; 18(3):349-58. PubMed ID: 6086470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibodies to the herpes simplex virus type-2-induced tumor-associated antigen AG-4 as markers of recurrence in cervical cancer.
    te Velde ER; Aurelian L
    Tumour Biol; 1987; 8(1):26-33. PubMed ID: 3037680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Herpesvirus type 2-induced tumour-specific antigen (AG-4) and specific antibody in patients with cervical cancer and controls.
    Aurelian L; Cornish JD; Smith MF
    IARC Sci Publ (1971); 1975; (11 Pt 2):79-87. PubMed ID: 191387
    [No Abstract]   [Full Text] [Related]  

  • 19. Prospective studies of the association of genital herpes simplex infection and cervical anaplasia.
    Nahmias AJ; Naib ZM; Josey WE; Franklin E; Jenkins R
    Cancer Res; 1973 Jun; 33(6):1491-7. PubMed ID: 4352387
    [No Abstract]   [Full Text] [Related]  

  • 20. Herpes simplex type 2 virus and cervical neoplasia.
    Vonka V; Kanka J; Roth Z
    Adv Cancer Res; 1987; 48():149-91. PubMed ID: 3039809
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.